SUBJECTS : Infectious Disease
GMS Infectious Diseases: 2020, vol: 8, issue:
- 1)- Gerd E Gross, Lisa Eisert, Hans Wilhelm Doerr, Helmut Fickenscher, Markus Knuf, Philip Maier, Matthias Maschke, Rainer Müller, Uwe Pleyer, Michael Schäfer, Cord Sunderkötter, Ricardo N Werner, Peter Wutzler, Alexander Nast. [S2k guideline for the diagnosis and therapy of zoster and post-zoster neuralgia]. GMS infectious diseases. 2020, 8: Doc01
Cited : 0Read More - 2)- Amanda L Lewis, Nicole M Gilbert. Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models. GMS infectious diseases. 2020, 8: Doc02Cited : 0Read More
- 3)- Michael Wilke, Claudia Hübner, Wolfgang Kämmerer. Calculated parenteral initial treatment of bacterial infections: Economic aspects of antibiotic treatment. GMS infectious diseases. 2020, 8: Doc03Cited : 0Read More
- 4)- Béatrice Grabein, Michael Ebenhoch, Ernst Kühnen, Florian Thalhammer. Calculated parenteral initial treatment of bacterial infections: Infections with multi-resistant Gram-negative rods - ESBL producers, carbapenemase-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter baumannii. GMS infectious diseases. 2020, 8: Doc04Cited : 0Read More
- 5)- Peter Walger, Hans Jürgen Heppner. Calculated parenteral initial therapy of bacterial infections: Antibiotic treatment in the elderly. GMS infectious diseases. 2020, 8: Doc05Cited : 0Read More
- 6)- Reinier Mutters, Peter Walger, Christoph Lübbert. Calculated initial parenteral treatment of bacterial infections: Bacterial gastrointestinal infections. GMS infectious diseases. 2020, 8: Doc06Cited : 0Read More
- 7)- Pramod M Shah, Reinhard Brodt, Thomas A Wichelhaus, Roland Nau. Calculated parenteral initial therapy of bacterial infections: Bacterial meningitis. GMS infectious diseases. 2020, 8: Doc07Cited : 0Read More
- 8)- Pascal M Dohmen, Klaus Friedrich Bodmann, Wolfgang Graninger, Pramod Shah, Florian Thallhammer. Calculated initial parenteral treatment of bacterial infections: Bacterial endocarditis. GMS infectious diseases. 2020, 8: Doc08Cited : 0Read More
- 9)- Klaus-Friedrich Bodmann, Rainer Höhl, Wolfgang Krüger, Beatrice Grabein, Wolfgang Graninger. Calculated initial parenteral treatment of bacterial infections: Sepsis. GMS infectious diseases. 2020, 8: Doc09Cited : 0Read More
- 10)- Mathias G Vossen, Rainer Gattringer, Florian Thalhammer, Matthias Militz, Gunnar Hischebeth. Calculated parenteral initial treatment of bacterial infections: Bone and joint infections. GMS infectious diseases. 2020, 8: Doc10Cited : 0Read More
- 11)- Cord Sunderkötter, Karsten Becker, Christian Eckmann, Wolfgang Graninger, Peter Kujath, Helmut Schöfer. Calculated initial parenteral treatment of bacterial infections: Skin and soft tissue infections. GMS infectious diseases. 2020, 8: Doc11Cited : 0Read More
- 12)- Reinhard Fünfstück, Udo Hoyme, Kurt Naber, Adrian Pilatz, Sören Schubert, Florian Wagenlehner. Calculated parenteral initial treatment of bacterial infections: Infections of the kidneys and the genito-urinary tract. GMS infectious diseases. 2020, 8: Doc12Cited : 0Read More
- 13)- Christian Eckmann, Rainer Isenmann, Peter Kujath, Annette Pross, Arne C Rodloff, Franz-Josef Schmitz. Calculated parenteral initial treatment of bacterial infections: Intra-abdominal infections. GMS infectious diseases. 2020, 8: Doc13Cited : 0Read More
- 14)- Bernhard Olzowy, Bilal Al-Nawas, Miriam Havel, Julia Karbach, Rainer Müller. Calculated parenteral initial treatment of bacterial infections: Infections in the ear, nose, throat and mouth and jaw area. GMS infectious diseases. 2020, 8: Doc14Cited : 0Read More
- 15)- Sebastian R Ott, Klaus-Friedrich Bodmann, Béatrice Grabein, Gert Höffken, Martin Kolditz, Hartmut Lode, Mathias W Pletz, Florian Thalhammer. Calculated parenteral initial treatment of bacterial infections: Respiratory infections. GMS infectious diseases. 2020, 8: Doc15Cited : 0Read More
- 16)- Ralf Stahlmann, Hartmut Lode. Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty. GMS infectious diseases. 2020, 8: Doc16Cited : 0Read More
- 17)- Hartmut Derendorf, Tobias Heinrichs, Tobias Reimers, Cordula Lebert, Alexander Brinkmann. Calculated initial parenteral treatment of bacterial infections: Pharmacokinetics and pharmacodynamics. GMS infectious diseases. 2020, 8: Doc17Cited : 0Read More
- 18)- Michael Kresken, Béatrice Grabein, Karsten Becker, Eberhard Straube, Thomas A Wichelhaus, Birgit Willinger. Calculated parenteral initial treatment of bacterial infections: Microbiology. GMS infectious diseases. 2020, 8: Doc18Cited : 0Read More
- 19)- Klaus-Friedrich Bodmann, Michael Kresken, Béatrice Grabein, Pascal M Dohmen, Michael Wilke. Calculated parenteral initial treatment of bacterial infections: Introduction and antibiotics. GMS infectious diseases. 2020, 8: Doc19Cited : 0Read More
- 20)- Klaus-Friedrich Bodmann, Béatrice Grabein, Michael Kresken. S2k guideline "Calculated parenteral initial treatment of bacterial infections in adults - update 2018", 2 updated version: Foreword. GMS infectious diseases. 2020, 8: Doc20Cited : 0Read More
- 21)- José Antonio Ortega Martell. Immunology of urinary tract infections. GMS infectious diseases. 2020, 8: Doc21Cited : 0Read More
- 22)- Nele Wellinghausen, Meike Voss, Ralitsa Ivanova, Susanne Deininger. Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays. GMS infectious diseases. 2020, 8: Doc22Cited : 0Read More
- 23)- Percy Schröttner, Eric Tille, Christian Lück, Boyke Bunk. Wound infection caused by Photobacterium damselae in a 32-year-old woman: case report and review of the literature. GMS infectious diseases. 2020, 8: Doc23Cited : 0Read More
- 24)- József Horváth, Björn Wullt, Kurt G Naber, Béla Köves. Biomarkers in urinary tract infections - which ones are suitable for diagnostics and follow-up? GMS infectious diseases. 2020, 8: Doc24Cited : 0Read More
- 25)- Michael Wilke, Wolfgang Heinlein, Luis Stiefenhofer, Klaus-Friedrich Bodmann. Clinical and economical improvements after introducing rapid identification of bacteria and early antibiotic susceptibility testing in sepsis and bloodstream infections. Results of the PHENOMENON study. GMS infectious diseases. 2020, 8: Doc25Cited : 0Read More
